Pancreatic Cancer Battle Intensifies: Biotech Innovations Aim to Boost Survival Rates
ONCYOncolytics Biotech (ONCY) Prnewswire·2024-05-23 23:51

USA News Group Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, May 23, 2024 /PRNewswire/ -- USA News Group – Known as one of the deadliest cancers, researchers are working diligently to help increase the chance of survival for pancreatic cancer patients through earlier detection, as according to Johns Hopkins Medicine up to 80% of patients, are diagnosed at later, more difficult-to-treat stages. Now, researchers have identified specific circulating microRNAs (miRNAs) in blood samples t ...